Marché des injectables lyophilisés – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00004411
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 200
Buy Now

Le marché des injectables lyophilisés devrait atteindre 4 001,27 millions de dollars US d'ici 2028, contre 2 719,42 millions de dollars US en 2021 ; il devrait croître à un TCAC de 5,8 % de 2022 à 2028.





Les principaux facteurs qui animent le marché sont la demande croissante de recherche contractuelle services de fabrication, l'augmentation des approbations de produits pharmaceutiques et la demande croissante de produits biologiques. Cependant, les rappels de produits freinent la croissance du marché.





Les injectables lyophilisés sont des médicaments lyophilisés qui sont stables pendant le transport. Ils sont conservés dans des flacons à usage unique, une reconstitution au point de service et des emballages spécialisés pendant une période plus longue. Au moment de l'utilisation, la quantité requise de médicaments peut être reconstituée à l'aide de diluants. Les injectables lyophilisés sont également appelés injectables lyophilisés car ils sont fabriqués par le procédé de lyophilisation, une technique consistant à isoler un matériau solide d'un solvant en congelant et en évaporant la solution sous vide. Les injections lyophilisées sont souvent considérées comme la meilleure alternative aux formes posologiques solides orales. Dans de nombreuses études de cas, les injections ont énormément profité aux patients alités. Des injections lyophilisées sont également prescrites pour atteindre une biodisponibilité et une stabilité maximales chez les patients souffrant de plusieurs maladies, car ces injectables ont une durée de conservation plus longue que les autres formes posologiques.





< strong>Insights stratégiques





Régions lucratives pour le marché mondial des injectables lyophilisés



< p>Régions lucratives pour le marché mondial des injectables lyophilisés



Informations sur le marché



L'augmentation des approbations de produits pharmaceutiques stimule la croissance du marché



Des études en cours émergent sur l'innocuité et l'efficacité de nouveaux agents thérapeutiques lyophilisés utilisés chez les patients adultes hospitalisés diagnostiqués avec le COVID-19. Fabricants du le marché des injectables lyophilisés  reçoit les approbations de la FDA américaine pour l'autorisation d'utilisation d'urgence (EUA) de ces innovations pour traiter les patients souffrant de symptômes sévères du COVID-19.





Depuis la pandémie de COVID-19, les acteurs du marché mondial des injectables lyophilisés redoublent d'efforts pour obtenir l'approbation des organismes de réglementation, tels que le Drug Controller General of India (DCGI), pour une utilisation d'urgence restreinte en Inde . Les approbations croissantes de produits pharmaceutiques, tels que Remdesivir, conduisent finalement à une forte demande de produits injectables lyophilisés. Voici quelques exemples de produits pharmaceutiques approuvés par la FDA et d'autres organismes de réglementation.



  • En février 2020, Mylan a obtenu l'approbation réglementaire de DCGI pour la poudre lyophilisée Remdesivir en Inde pour une utilisation d'urgence restreinte chez les patients COVID-19.
  • En juin 2020, Cipla a lancé Cipremi, la poudre lyophilisée Remdesivir pour injection. De plus, la FDA américaine a délivré une autorisation d'utilisation d'urgence (EUA) à Gilead Sciences Inc. pour une utilisation d'urgence du Remdesivir pour traiter le COVID- 19 patients. Il s'agit du seul traitement EUA approuvé par la FDA pour les patients adultes et pédiatriques hospitalisés avec une infection COVID-19 suspectée ou confirmée en laboratoire. Ainsi, en mai, Gilead Sciences Inc. a étendu une licence volontaire non exclusive à Cipla pour fabriquer et commercialiser Cipla&rsquo ;s version générique de remedisvir appelée CIPREMI. 
  • En juillet 2020, Jubilant Life a reçu l'approbation du Drug Controller General of India (DCGI) pour fabriquer et commercialiser Remdesivir pour 100 mg/flacon (injection lyophilisée) pour une utilisation d'urgence restreinte en Inde pour le traitement de COVID-19 sévère.
  • En août 2020, la poudre lyophilisée Cosentyx dans un flacon à usage unique de Novartis AG a reçu l'approbation de l'UE. Le médicament approuvé a été très productif pour améliorer rapidement les symptômes cutanés et améliorer la qualité de vie des patients souffrant de psoriasis. 

Ainsi, les approbations croissantes à travers le monde propulsent la croissance du marché des injectables lyophilisés.





Insights basés sur le type d'emballage



Le marché mondial des injectables lyophilisés, basé sur le type d'emballage, est segmenté en flacons à usage unique, reconstitution au point de service et emballages spécialisés. En 2021, le segment des flacons à usage unique représentait la plus grande part de marché, alors que le segment des emballages spécialisés devrait enregistrer le TCAC le plus élevé de 6,7 % au cours de la période de prévision.





Insights basés sur le type de diffusion



Sur la base du type de livraison, le marché mondial des injectables lyophilisés est segmenté en seringues de diluant préremplies, dispositifs de reconstitution exclusifs, dispositifs en une seule étape et dispositifs en plusieurs étapes. Le segment des seringues de diluant préremplies détenait le plus grand marché part en 2021 et devrait enregistrer le TCAC le plus élevé de 6,3 % au cours de la période de prévision.





Insights basés sur les indications



Sur la base des indications, le marché mondial des injectables lyophilisés est segmenté en conditions métaboliques et oncologiques, maladies infectieuses, maladies auto-immunes et autres indications. Le segment des maladies métaboliques et oncologiques détenait la plus grande part de marché en 2021 et devrait enregistrer le TCAC le plus élevé de 6,2 %. pendant la période de prévision.





Insights basés sur l'utilisateur final     



Sur la base de l'utilisateur final, le marché mondial des injectables lyophilisés est segmenté en hôpitaux, centres de chirurgie ambulatoire, cliniques spécialisées et autres. Le segment des hôpitaux détenait la plus grande part de marché en 2021. Cependant, le segment des cliniques spécialisées on estime qu'il enregistre le TCAC le plus élevé de 6,3 % sur le marché au cours de la période de prévision.





Marché mondial des injectables lyophilisés, par type d'emballage - 2021 et 2028



Marché mondial des injectables lyophilisés, par type d'emballage – 2021 et 2028



Les entreprises opérant sur le marché mondial des injectables lyophilisés adoptent la stratégie d'innovation de produits pour répondre à l'évolution des demandes des clients à travers le monde, ce qui leur permet également de maintenir leur marque sur le marché mondial. Par exemple, en avril 2022, Recipharm acquiert le CDMO de thérapie avancée Arranta Bio et le CDMO de virothérapie Vibalogics. L'acquisition a également permis à Recipharm d'établir une base solide aux États-Unis, avec des installations à Boxborough, MA, et de fournir une plate-forme à partir de laquelle développer ses capacités dans de nouvelles modalités biologiques.





Marché mondial des injectables lyophilisés – par géographie



Géographiquement, le marché mondial des injectables lyophilisés est segmenté en Amérique du Nord (États-Unis, Canada et Mexique) , Europe (Allemagne, Royaume-Uni, France, Italie, Espagne et reste de l'Europe), Asie-Pacifique (Chine, Inde, Japon, Corée du Sud, Australie et reste de l'APAC), Moyen-Orient & Afrique (Afrique du Sud, Arabie saoudite, Émirats arabes unis et reste de la MEA) et Amérique du Sud et centrale (Brésil, Argentine et reste de l'Amérique du Sud et centrale).





Profils d'entreprise



  • Baxter
  • Nipro
  • Curia Global, Inc.
  • Recipharm AB
  • Vetter Pharma
  • Jubilant HollisterStier LLC (Jubilant Pharma Limited)
  • Aristopharma Ltd.
  • CordenPharma International
  • Credence MedSystems, Inc.
  • SG Biopharm Pvt.Ltd
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is meant by the lyophilized injectable market?

Lyophilized injectables are freeze-dried drugs that are more stable and can be transported and stored for a longer period. At the time of use, the required quantity of drugs can be reconstituted with the help of diluents. Lyophilized injectable are also termed as freeze-dried injectable as they are produced by the lyophilization process which is the technique of isolating a solid material from a solvent by freezing and evaporating the solution under vacuum. The lyophilized injectable market is segmented into type of packaging, type of delivery, indication, end user, and geography.

What are the driving factors for the lyophilized injectable market across the globe?

Increasing demand of contract research manufacturing services and rising approvals of pharmaceuticals are the most significant factors responsible for the overall market growth.

Which type of packaging segment held the largest market share in the lyophilized injectable market?

Based on type of packaging, single-use vials segment took the forefront lead in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Which type of delivery segment led the lyophilized injectable market?

Based on type of delivery, prefilled diluent syringes segment accounted for the largest share in 2021 in the worldwide market and is expected to continue to do so till the forecast period.

Which indication segment held the largest market share in the lyophilized injectable market?

The metabolic and oncology conditions segment dominated the indication segment in the global lyophilized injectable market and accounted for the largest market share of 46.05% in 2021.

Which end user segment led the lyophilized injectable market?

Based on end user, hospital segment took the forefront lead in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.

Who are the key players in the lyophilized injectable market?

Baxter, Nipro, Curia Global, Inc., Recipharm AB, Vetter Pharma, Jubilant HollisterStier (Jubilant Pharma Limited), Aristopharma Ltd., CordenPharma International, Credence MedSystems, Inc., and S. G. Biopharm Pvt. Ltd. are among the leading companies operating in the lyophilized injectable market.

What is the regional market scenario of the lyophilized injectable market?

Global lyophilized injectable market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for lyophilized injectable market. The growth of the market in North America is expected due to the factors such as increasing demand for lyophilized injectable for safer packaging and prolonged shelf life, growing pharmaceutical production due to pandemic, and rising research and development in the healthcare industry. Further, the growing research & development activities owing to the investments by biotechnology, pharmaceutical, and biopharmaceutical companies and the rise in the research & applications of the lyophilized injectable drug in various fields are the key factors responsible for the Asia-Pacific regional growth for lyophilized injectable accounting for the fastest growth of the region during the coming years.

The List of Companies - Lyophilized Injectable Drugs Market

  1. Baxter
  2. Nipro
  3. Curia Global, Inc.
  4. Recipharm AB
  5. Vetter Pharma
  6. Jubilant HollisterStier LLC (Jubilant Pharma Limited)
  7. Aristopharma Ltd.
  8. CordenPharma International
  9. Credence MedSystems, Inc.
  10. S. G. Biopharm Pvt. Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports